HST Global (HST Global) Growth Rank : 0 (As of May. 25, 2024)

View and export this data going back to 2002. Start your Free Trial

What is HST Global Growth Rank?

HST Global has the Growth Rank of 0.

GuruFocus Growth Rank measures the growth of a company in terms of its revenue and profitability. Historically, the companies with the highest growth ranks performed the best over the long term. It is calculated using the following criteria:

1. 5-year revenue growth rate, the higher, the better.
2. 3-year revenue growth rate, the higher, the better.
3. 5-year EBITDA growth rate, the higher, the better.
4. The predictability of 5-year revenue. The most consistent it is, the higher the rank.

GuruFocus found that the Growth Rank is the second of the two most-sensitive parameters among the five parameters checked. Please click GF Score to see more details on GF Score's 5 Key Aspects of Analysis.

Please note that we are using the five-year EBITDA growth rate as a parameter, so the company needs to have had positive growth over that time. The reason we use EBITDA instead of earnings per share is that with EBITDA, we can rank a lot more companies since a company may have positive EBITDA but negative EPS. Since we are looking at the growth here, EBITDA gives us a pretty clear picture about the growth in the company's business operations.

HST Global Growth Rank Related Terms

Thank you for viewing the detailed overview of HST Global's Growth Rank provided by GuruFocus.com. Please click on the following links to see related term pages.

HST Global (HST Global) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » HST Global Inc (OTCPK:HSTC) » Definitions » Growth Rank

Comparable Companies

Traded in Other Exchanges

N/A

Address

150 Research Drive, Hampton, VA, USA, 23666

Website

http://www.hstglobal.com

HST Global Inc is an integrated health and wellness biotechnology company. It is engaged in developing and acquiring a network of Wellness Centers that are focused on the homeopathic and alternative treatment of late-stage cancer. Further, it primarily focuses on homeopathic and alternative product candidates that are undergoing or have already completed clinical testing. The activities are generally carried out through the region of the United States.

Executives

Wesley D. Tate	officer: CFO and Secretary	C/O HEALTH SOURCE TECHNOLOGIES, INC., 150 RESEARCH DRIVE, HAMPTON VA 23666
Ronald R. Howell	director, officer: CEO and Chairman	C/O HEALTH SOURCE TECHNOLOGIES, INC., 150 RESEARCH DRIVE, HAMPTON VA 23666
Pnc Labs Inc	10 percent owner	429 W PLUMB LANE, RENO NV 89509
Chun Ka Tsun	director, 10 percent owner, officer: CEO	TG WANASPORTS MANAGEMENT HOLDINGS, 8/F NO 211 JOHNSTON ROAD, WAN CHAI K3 00000
Chen Tsz King	10 percent owner	FUGU ENTERPRISE INC, UNIT A 8TH FLOOR NO 65 SING WOOD ROAD, HAPPY VALLEY K3 00000
Li Sze Tang	10 percent owner	FLAT G, 8/FL TOWER THREE, THE WATERFRONT, 1 AUSTIN ROAD WEST, TST K3 00000
Andre E Todd	director	746 HILLGIRT CIRCLE, OAKLAND CA 94610
Aaron Etra	director	1350 AVE OF AMERICAS, 29TH FLOOR, NEW YORK NY 10019
Communications Holding Corp	10 percent owner
Alan Lew	director, 10 percent owner, officer: President	2 DOGWOOD DR, SCARSDALE NY 10583

HST Global (HST Global) Headlines

From GuruFocus

HST Global, Inc. Announces Entering into an Agreement to Purchase a Financial Services Revenue Sharing Contract.

By Marketwired Marketwired • 08-23-2019